Hansen Medical Announces 2008 Second Quarter Conference Call
* Reuters is not responsible for the content in this press release.
MOUNTAIN VIEW, CA, Jul 23 (MARKET WIRE) --
Hansen Medical, Inc. (NASDAQ: HNSN), a developer of new generation
flexible robotic technology, announced today that it will release its
financial and operating results for the second quarter ended June 30,
2008 after market close on Thursday, July 31, 2008.
Hansen Medical will host a conference call at 5:00 p.m. EDT (2:00 p.m.
PDT) on July 31, 2008 to discuss its results. The call may be accessed by
dialing 800-366-7449 (303-262-2175 for international callers) and via the
Internet in the Investor Relations section of Hansen Medical's website at
www.hansenmedical.com. Please go to the website at least 15 minutes early
to register, download and install any necessary audio software. Following
the call, a webcast replay will be available on Hansen Medical's website,
and an audio replay will also be available by calling 800-405-2236
(303-590-3000 for international callers) and entering the passcode
11117047. Both the audio and webcast replays will be available through
August 7, 2008.
About Hansen Medical, Inc.
Hansen Medical, Inc., based in Mountain View, Calif., develops products
and technology using robotics for the accurate positioning, manipulation
and control of catheters and catheter-based technologies. Its first
product, the Sensei(TM) Robotic Catheter system, is a robotic navigation
system that enables clinicians to place mapping catheters in
hard-to-reach anatomical locations within the heart easily, accurately
and with stability during complex cardiac arrhythmia procedures. The
Sensei system is compatible with fluoroscopy, ultrasound, 3D surface map
and patient electrocardiogram data and was cleared by the U.S. Food and
Drug Administration (FDA) in May 2007 for manipulation and control of
certain mapping catheters in Electrophysiology (EP) procedures. The
safety and effectiveness of the Sensei system for use with cardiac
ablation catheters in the treatment of cardiac arrhythmias, including
atrial fibrillation (AF), have not been established. In the European
Union, the Sensei system is cleared for use during EP procedures, such as
guiding catheters in the treatment of AF. Additional information can be
found at www.hansenmedical.com.
Hansen Medical, Hansen Medical Heart Design logo, Sensei, Artisan,
Instinctive Motion, IntelliSense, and Fine Force Technology are trademarks
of Hansen Medical, Inc. in the United States and other countries. All
trademarks and registered trademarks are property of their respective
owners.
Investor Contact:
Steven Van Dick
650.404.5800
Email Contact
Media Contact:
Amy Cook
925.552.7893
Email Contact
Lasse Glassen
Financial Relations Board
213.486.6546
Email Contact
Copyright 2008, Market Wire, All rights reserved.
-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters